‘Misleading claim will attract…’: Ayush ministry warns ayurvedic drug makers

The Ministry of Ayush has reportedly issued a warning to all ayurvedic, siddha, unani and homeopathic drug makers after the Supreme Court pulled up Patanjali Ayurved Ltd in connection with a misleading advertisement case.

In accordance with News 18, Ayushi’s ministry issued the warning, asking drug makers to “strictly enforce labeling and advertising norms.” Failure to comply with the regulations may attract legal action, the report added.

News 18 accessed the ministry’s clarification, according to the report, adding that the warning was related to products that make “unsubstantiated” claims or display false information, such as a “green logo” that claims to be 100% vegetarian. ” or falsely. indicating that the medicine is approved or certified by the ministry”.

READ ALSO: Patanjali in court: SC pulls up company, warns FMCG companies against misleading ads

Any misleading claim or advertisement in any form or platform will lead to consequential legal action by the relevant authorities,” the notice was quoted by News 18. The notice also mentioned details about all the laws and regulations that cover misleading ads in the country.

According to reports, the ministry directed state drug licensing officials to scrutinize all such drugs that claimed to be certified or approved by the Ministry of Ayush,” either on their labels or in advertisements. It also asked officials to guarantee compliance.

READ ALSO: Patanjali arrested by the SC: Truth matters in advertising

“Ayush ministry has no role in granting manufacturing licences”

The notice said that the license from the state drug licensing authority should not be construed as an approval by the Ministry of Ayush,” the report added.

It has been reported from the Ministry of Ayush that some manufacturers of Ayush medicines are mentioning ‘Certified or approved by the Ministry of Ayush’ on the label of their medicine or product or advertisement in print and electronic media,” according to the notice.

READ ALSO: Patanjali’s ads cast a long shadow over the FMCG sector

News 18 further reported that the ministry clarified that it has no role in granting licenses or manufacturing approvals to any Ayush medicine or product.

It even warned that in future, any such claim on the label or advertisement will attract consequential legal action against the alleged manufacturer by the Ministry of Ayush.”

READ ALSO: ‘Apologize only later…’: Supreme Court rejects Ramdev’s apology in Patanjali misleading ads case

The notice further adds that a license issued by a state authority is only permission to manufacture or sell a particular drug or product based on compliance with the conditions of the Drug and Cosmetic Act of 1940.

The notice has also been sent to the National Center for Pharmacovigilance Coordination, which monitors and designs the safety profiles of medicines, including issuing alerts, in case any medicine shows new side effects.

READ ALSO: Baba Ramdev and Acharya Balkrishna apologize unreservedly for Patanjali’s misleading advertisements

According to News 18, the Center was asked to ensure the reporting of such claims of approval or certification by the Ministry of Ayush to the concerned State Licensing Authority under a direction to that Ministry of Ayush.”

The warning came after yoga guru Ramdev and his aide Balkrishna of Patanjali Ayurved Ltd tendered an “unconditional and unconditional apology” to the Supreme Court for advertisements issued by the company making tall claims about the medicinal efficacy of their products.

Unlock a world of perks! From insightful newsletters to real-time stock tracking, breaking news and a personalized news feed, it’s all here, just a click away! Sign in now!

Catch all the latest business news, market news, breaking news events and news updates on Live Mint. Download Mint News app for daily market updates.

More Less

Posted: 27 Apr 2024, 18:58 IST

#Misleading #claim #attract.. #Ayush #ministry #warns #ayurvedic #drug #makers
Image Source : www.livemint.com

Leave a Comment